Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Computational biology focuses on the development and application of data-analytical and theoretical methods, mathematical modeling and computational simulation techniques in life sciences.

Statistics:

The global computational biology market is estimated to account for US$ 12,601.1 Mn in terms of value by the end of 2027.

Global Computational Biology Market: Drivers

High cost of drug development is expected to propel growth of the global computational biology market over the forecast period. For instance, according to an analysis published in JAMA in March 2020, U.S. biopharmaceutical companies spent around US$ 1 billion to bring each of their new drugs to market between 2009 and 2018.

Moreover, several benefits of computational biology are also expected to aid in growth of the market. Predictive modeling tools in computational biology can provide invaluable information to better streamline drug development process. Predictive modelling helps to reduce the total number of recruited patients and to shorten the duration of clinical trials.

Statistics:

North America held dominant position in the global computational biology market in 2019, accounting for 44.2% share in terms of value, followed by Europe and Asia Pacific, respectively

Figure 1: Global Computational Biology Market Share (%) Value, By Region, 2019

Computational Biology  | Coherent Market Insights

Global Computational Biology Market: Restraints

Enormous data with lack of standardization has limited the growth of computational biology market. There is rise in need for combination of the available software to build a composite application for current single task tools. The tools should be compatible with each other and should be able to use the same data effectively. User friendly databases are needed to reduce the time and effort currently being spent on the analysis of petabytes of data available with institutions and governments across the world.

Moreover, issues with data storage and organization are also limiting growth of the market. Rapid data accumulation poses challenges in organizing the data as it is diverse and may belong to populations, disease associations, symptoms, therapeutic drugs, and others.

request-sample

Computational Biology Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 3,453.2 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 17.6% 2027 Value Projection: US$ 12,601.1 Mn
Geographies covered (27):
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
  • Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: North Africa, Central Africa, South Africa
Segments covered:
  • By Type
    • Cellular & Biological Simulation: Computational Genomics, Computational Proteomics, Pharmacogenomics, Others (Transcriptomics/Metabolomic).
    • Disease Modeling and Simulation Applications: Drug Discovery, Drug Development.
  • By Tools: Content/Database, Analysis Software & Services, IT Infrastructure (Hardware).
Companies covered:

Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.

Growth Drivers:
  • Increasing prevalence of chronic disorders
Restraints & Challenges:
  • High Cost of Infrastructure

Global Computational Biology Market: Opportunities

Developing computer networks for surveillance of disease and mapping the pathways and biological networks associated with the initiation is expected to offer lucrative growth opportunities for players in the global computational biology market.

Moreover, increasing prevalence of chronic disorders is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.      

Statistics:

The global computational biology market was valued at US$ 3,453.2 Mn in 2019 and is forecast to reach a value of US$ 12,601.1 Mn by 2027 at a CAGR of 17.6% between 2020 and 2027.

Figure 2: Global Computational Biology Market Value (US$ Mn), 2016 – 2027

Computational Biology  | Coherent Market Insights

Market Trends/Key Takeaways

Increasing focus on reducing cost of drug development has led to manufacturers to adopt 3D modeling systems to analyze samples. Use of 3D modeling systems aids in recording rare cell events, accurate cell counts, improved sensitivity of detection, thereby accelerating the drug discovery process.

Major players in the market are focused on launching products and services that aid in treatment and management of Covid-19. For instance, in April 2020, Certara L.P. launched the COVID-19 Pharmacology Resource Center to help advance therapeutics for COVID-19.

Global Computational Biology Market: Competitive Landscape

Major players operating in the global computational biology market include, Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia  Pharma SAS, Schrodinger, and Simulation Plus, Inc.

Global Computational Biology Market: Key Developments

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in May 2020, Genedata, AG launched Genedata Imagence 2.0, the latest version of its enterprise software for high-content screening (HCS) image analysis.  

Major players in the market are also focused on adopting collaboration strategies to enhance their market share. For instance, in March 2019, Rosa & Co. LLC collaborated with Chugai Pharmaceutical Co., Ltd. Under the collaboration Rosa & Co. LLC will provide its PhysioPD research services for R&D in multiple therapeutic areas.

Computational Biology are used of data-analytical and theoretical methods, mathematical modeling and computational simulation techniques in life sciences. Predictive modeling tools provide vital information for better streamlining of drug development process thus reducing time and increasing efficiency. Increasing use of bioinformatics tools along with increasing investment in research and development is expected to propel the market growth during the forecast period. Furthermore, increasing patient population suffering from chronic diseases, increasing adoption of cloud computing for data storage is also anticipated to assist the growth of the market during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Computational Biology market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Computational Biology market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Computational Biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Computational Biology market

Detailed Segmentation:

  • Global Computational Biology Market, By Type:
    • Cellular & Biological Simulation
      • Computational Genomics
      • Computational Proteomics
      • Pharmacogenomics
      • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
      • Drug Discovery
      • Drug Development
  • Global Computational Biology Market, By Tools:
    • Content/Database
    • Analysis Software & Services
    • IT Infrastructure (Hardware)
  • Global Computational Biology Market, By Region:
    • North America
      • By Type:
        • Cellular & Biological Simulation
          • Computational Genomics
          • Computational Proteomics
          • Pharmacogenomics
          • Others (Transcriptomics/Metabolomic)
        • Disease Modeling and Simulation Applications
          • Drug Discovery
          • Drug Development
      • By Tools
        • Content/Database
        • Analysis Software & Services
        • IT Infrastructure (Hardware)
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Type:
        • Cellular & Biological Simulation
          • Computational Genomics
          • Computational Proteomics
          • Pharmacogenomics
          • Others (Transcriptomics/Metabolomic)
        • Disease Modeling and Simulation Applications
          • Drug Discovery
          • Drug Development
      • By Tools
        • Content/Database
        • Analysis Software & Services
        • IT Infrastructure (Hardware)
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Type:
        • Cellular & Biological Simulation
          • Computational Genomics
          • Computational Proteomics
          • Pharmacogenomics
          • Others (Transcriptomics/Metabolomic)
        • Disease Modeling and Simulation Applications
          • Drug Discovery
          • Drug Development
      • By Tools
        • Content/Database
        • Analysis Software & Services
        • IT Infrastructure (Hardware)
      • By Country
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Type:
        • Cellular & Biological Simulation
          • Computational Genomics
          • Computational Proteomics
          • Pharmacogenomics
          • Others (Transcriptomics/Metabolomic)
        • Disease Modeling and Simulation Applications
          • Drug Discovery
          • Drug Development
      • By Tools
        • Content/Database
        • Analysis Software & Services
        • IT Infrastructure (Hardware)
      • By Country
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Type:
        • Cellular & Biological Simulation
          • Computational Genomics
          • Computational Proteomics
          • Pharmacogenomics
          • Others (Transcriptomics/Metabolomic)
        • Disease Modeling and Simulation Applications
          • Drug Discovery
          • Drug Development
      • By Tools
        • Content/Database
        • Analysis Software & Services
        • IT Infrastructure (Hardware)
      • By Country
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • By Type:
        • Cellular & Biological Simulation
          • Computational Genomics
          • Computational Proteomics
          • Pharmacogenomics
          • Others (Transcriptomics/Metabolomic)
        • Disease Modeling and Simulation Applications
          • Drug Discovery
          • Drug Development
      • By Tools
        • Content/Database
        • Analysis Software & Services
        • IT Infrastructure (Hardware)
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Accelrys *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Certara, L.P.
    • Chemical Computing Group Inc.
    • Compugen, ltd.
    • Entelos, Inc. (Rosa & Co. LLC)
    • Genedata AG
    • Insilico Biotechnology AG
    • Leadscope, Inc.
    • Nimbus Discovery LLC
    • Rhenovia  Pharma SAS
    • Schrodinger
    • Simulation Plus, Inc.
  •  “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By Tools
      • Market Snippet, By Country
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Technological Advancements
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Global Computational Biology Market, By Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Cellular & Biological Simulation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Computational Genomics
        • Computational Proteomics
        • Pharmacogenomics
        • Others (Transcriptomics/Metabolomic)
    • Disease Modeling and Simulation Applications
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Drug Discovery
        • Drug Development
  5. Global Computational Biology Market, By Tools, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Content/Database
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Analysis Software & Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • IT Infrastructure (Hardware)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Computational Biology Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Tools, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Tools, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Tools, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Tools, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Tools, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Tools, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • Accelrys
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Certara, L.P.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Chemical Computing Group Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Compugen, ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Entelos, Inc. (Rosa & Co. LLC)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Genedata AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Insilico Biotechnology AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Leadscope, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Nimbus Discovery LLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Rhenovia  Pharma SAS
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Schrodinger
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Simulation Plus, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 22 market data tables and 14 figures on “Computational Biology Market - Global forecast to 2027”.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner